Vaccine treatment evaluation units
Ended Awarded Last action
- Contract number
- 75N93018F00027
- Awardee
-
University Of Maryland, Baltimore UEI Z9CRZKD42ZT1 Part of University System Of Maryland
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,438,832
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2012144 Solicitation number
- Vaccine and treatment evaluation units (vteu) Award Notice · Posted Mar 29, 2012
- Contract value 21% obligated
-
- $2,438,831.85 Current, with exercised options
- $11,622,050.85 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21201, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$1,319,490 | |
| Change Order | $1,655,920 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,102,841 | |
| Exercise an Option | $949,797 | |
| Original award | $49,764 |
About this award
This is a $11,622,050.85 firm fixed price delivery order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to the University of Maryland, Baltimore (UMB) to perform work under the Vaccine and Treatment Evaluation Units (VTEU) program. The award has no set-aside designation. The VTEU program supports biomedical and public health research initiatives, and this delivery order continues UMB's role in evaluating vaccine treatments. UMB is a subcomponent of the University System of Maryland (USM), which has separately received federal contracts and grants to provide infrastructure, research, and student services. Through this award, UMB will conduct the required work at its facilities in Baltimore, MD to support the VACCINE TREATMENT EVALUATION UNITS program through July 2027.
Quick answers
Who was awarded contract 75N93018F00027?
75N93018F00027 was awarded to University Of Maryland, Baltimore by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 30, 2018.
How much is contract 75N93018F00027 worth?
The government has obligated $2,438,832 on 75N93018F00027. Its potential value, with all options, is $11,622,051.
Is contract 75N93018F00027 an order under another contract?
Yes. 75N93018F00027 is a delivery order under HHSN272201300022I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).
Was contract 75N93018F00027 competed?
The extent of competition for 75N93018F00027 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award